Correlation Between NYSE Composite and Taro Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Taro Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Taro Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Taro Pharmaceutical Industries, you can compare the effects of market volatilities on NYSE Composite and Taro Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Taro Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Taro Pharmaceutical.
Diversification Opportunities for NYSE Composite and Taro Pharmaceutical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Taro is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Taro Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taro Pharmaceutical and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Taro Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taro Pharmaceutical has no effect on the direction of NYSE Composite i.e., NYSE Composite and Taro Pharmaceutical go up and down completely randomly.
Pair Corralation between NYSE Composite and Taro Pharmaceutical
If you would invest 1,923,895 in NYSE Composite on September 1, 2024 and sell it today you would earn a total of 103,309 from holding NYSE Composite or generate 5.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
NYSE Composite vs. Taro Pharmaceutical Industries
Performance |
| Timeline |
NYSE Composite and Taro Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Taro Pharmaceutical Industries
Pair trading matchups for Taro Pharmaceutical
Pair Trading with NYSE Composite and Taro Pharmaceutical
The main advantage of trading using opposite NYSE Composite and Taro Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Taro Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taro Pharmaceutical will offset losses from the drop in Taro Pharmaceutical's long position.| NYSE Composite vs. Acumen Pharmaceuticals | NYSE Composite vs. Mind Medicine | NYSE Composite vs. NL Industries | NYSE Composite vs. Ecovyst |
| Taro Pharmaceutical vs. ANI Pharmaceuticals | Taro Pharmaceutical vs. Phibro Animal Health | Taro Pharmaceutical vs. Prestige Brand Holdings | Taro Pharmaceutical vs. Amphastar P |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |